Home > Colorectal Cancer
Colorectal hhh cancer also called as cancer of the large intestine, occurs when the cells that line the colo nor the rectum become abnormal and grow out of control. Most cases of colorectal cancer begin as small, noncancerous (benign) clumps of cells called adenomatous polyps. Over time some of these polyps may turns cancerous. By colonoscopy, colon cancer and polyps can be visualised.

HNPCC, also called Lynch syndrome, increases the risk of colon cancer and other cancers. People with HNPCC tend to develop colon cancer before age 50.

FAP is a rare disorder that causes you to develop thousands of polyps in the lining of your colon and rectum. People with untreated FAP have a greatly increased risk of developing colon cancer before age 40.

Changes in bowel habits, including persistent constipation or diarrhoea, a feeling of not being able to empty the bowel completely, an urgency to move the bowels, or a change in the consistency of the stools ( long, thin 'pencil stools')

Rectal bleeding or dark patches of blood in or on stool

Persistent abdominal discomfort such as cramps, bloating, gas or pain

Unexplained fatigue, weakness, loss of appetite and/or weight loss

Pelvic pain, which occurs at later stages of the disease

People diagnosed with colon cancer are of older age (>50 years). Colon cancer can occur in younger people, but it occurs much less frequently.

Chronic inflammatory diseases of the colon, such as Ulcerative colitis and Crohn's disease, can increase your risk of colon cancer.

Personal history of Colorectal cancer.

Family history of colon cancer

Inherited syndromes that increase colon cancer risk.

Sedentary lifestyle

Smoking

Alcohol

Sexual exposure early in life

Oropharyngeal squamous carcinoma (OSCC)

Smoking is associated with squamous cell cervical cancer

Having other sexually transmitted infections (STIs)

Many sexual partners increases chance of acquiring HPV.

Giving birth to many children increases the risk of HPV

Persistent infection of the cervix with Human Papillomavirus (HPV)

Colonoscopy

CT Colonoscopy

Fecal occult blood test

Flexible sigmoidoscopy
Stages of colorectal cancer span from Stage I to Stage IV

Abnormal cells are found in the innermost lining of the colon or rectal wall (mucosa)
Cancer has formed in the mucosa (innermost layer) and has spread to the submucosa (layer of tissue under the mucosa) and muscle layer of colon or rectum
The cancer has grown through the wall of the colon or rectum to the lining of the abdomen, and has grown into nearby structures.
The cancer has grown throught the inner lining or into the muscle layers of the intestine and spread to lymph nodes.

In general, screening for colorectal cancer should begin at the age of 45, when the risk for developing colorectal polyps and cancer starts to increase.
Men and Women should under screening since colorectal polyps and cancer affect both genders.

However, if having a personal or a family history of colorectal polyps or cancer, screening may need to begin before age 45.
Discuss with the clinical to ensure what age is best to start your screening based on personal risk factors.

CEA; CARCINO EMBRYONIC ANTIGEN
CA 72.4; GASTRIC CANCER MARKER
HISTOPATHOLOGY BIOPSY: SMALL SPECIMEN
IMMUNOHISTOCHEMISTRY: CYTOKERATIN (PANCYTOKERATIN)
IMMUNOHISTOCHEMISTRY: Ki-67
HISTOPATHOLOGY BIOPSY: LARGE COMPLEX / CANCER SPECIMEN
IMMUNOHISTOCHEMISTRY: CYTOKERATIN- 7 (CK-7)
IMMUNOHISTOCHEMISTRY: CYTOKERATIN-20 (CK-20)
IMMUNOHISTOCHEMISTRY: CDX-2
IMUNOHISTOCHEMISTRY: MICROSATELLITE INSTABILITY PANEL
ONCOPRO HEREDITARY CANCER RISK PANEL
COMPLETE BLOOD COUNT; CBC
IMMUNOHISTOCHEMISTRY: CYTOKERATIN (PANCYTOKERATIN)
IMMUNOHISTOCHEMISTRY: Ki-67
IMMUNOHISTOCHEMISTRY: CYTOKERATIN- 7 (CK-7)
IMMUNOHISTOCHEMISTRY: CYTOKERATIN-20 (CK-20)
IMMUNOHISTOCHEMISTRY: CDX-2
IMUNOHISTOCHEMISTRY: MICROSATELLITE INSTABILITY PANEL
KRAS MUTATION CODON 12 & 13
CANCER 50 GENE PANEL, NGS
BRAF MUTATION ANALYSIS
CPIK3CA MUTATION ANALYSIS
CANCER GENE ANY 3 MARKERS, NGS
MICROSATELLITE INSTABILITY (MSI) PCR
ONCOPRO HEREDITARY CANCER RISK PANEL
ONCOPRO LIQUID BIOPSY
KRAS & NRAS MUTATION ANALYSIS PANEL
CANCER TARGETED GENE PANEL: COLON / COLORECTAL
ONCOPRO LIQUID BIOPSY
CANCER 50 GENE PANEL, NGS
ONCOPRO HEREDITARY CANCER RISK PANEL






